123 related articles for article (PubMed ID: 8662901)
21. Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance.
Dubaquié Y; Mortensen DL; Intintoli A; Hogue DA; Nakamura G; Rancatore P; Lester P; Sadick MD; Filvaroff E; Fielder PJ; Lowman HB
Endocrinology; 2001 Jan; 142(1):165-73. PubMed ID: 11145579
[TBL] [Abstract][Full Text] [Related]
22. A 30-kDa fragment of insulin-like growth factor (IGF) binding protein-3 in human pregnancy serum with strongly reduced IGF-I binding.
Ahlsén M; Carlsson-Skwirut C; Jonsson AP; Cederlund E; Bergman T; Bang P
Cell Mol Life Sci; 2007 Jul; 64(14):1870-80. PubMed ID: 17593323
[TBL] [Abstract][Full Text] [Related]
23. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
25. Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling.
Devi GR; Graham DL; Oh Y; Rosenfeld RG
Growth Horm IGF Res; 2001 Aug; 11(4):231-9. PubMed ID: 11735239
[TBL] [Abstract][Full Text] [Related]
26. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.
Headey SJ; Leeding KS; Norton RS; Bach LA
J Mol Endocrinol; 2004 Oct; 33(2):377-86. PubMed ID: 15525596
[TBL] [Abstract][Full Text] [Related]
27. Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action.
Allan GJ; Tonner E; Szymanowska M; Shand JH; Kelly SM; Phillips K; Clegg RA; Gow IF; Beattie J; Flint DJ
Endocrinology; 2006 Jan; 147(1):338-49. PubMed ID: 16195401
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the components of the 150 kDa IGF binding protein complex in cocultures of rat hepatocytes and Kupffer cells by 3',5'-cyclic adenosine monophosphate.
Scharf JG; Braulke T; Hartmann H; Ramadori G
J Cell Physiol; 2001 Mar; 186(3):425-36. PubMed ID: 11169982
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
Devi GR; Yang DH; Rosenfeld RG; Oh Y
Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
[TBL] [Abstract][Full Text] [Related]
30. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells.
Hong J; Zhang G; Dong F; Rechler MM
J Biol Chem; 2002 Mar; 277(12):10489-97. PubMed ID: 11784719
[TBL] [Abstract][Full Text] [Related]
32. Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins.
Roghani M; Lassarre C; Zapf J; Povoa G; Binoux M
J Clin Endocrinol Metab; 1991 Sep; 73(3):658-66. PubMed ID: 1714916
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II.
Oh Y; Nagalla SR; Yamanaka Y; Kim HS; Wilson E; Rosenfeld RG
J Biol Chem; 1996 Nov; 271(48):30322-5. PubMed ID: 8939990
[TBL] [Abstract][Full Text] [Related]
34. Transferrin binds insulin-like growth factors and affects binding properties of insulin-like growth factor binding protein-3.
Storch S; Kübler B; Höning S; Ackmann M; Zapf J; Blum W; Braulke T
FEBS Lett; 2001 Dec; 509(3):395-8. PubMed ID: 11749962
[TBL] [Abstract][Full Text] [Related]
35. The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3.
Coverley JA; Martin JL; Baxter RC
Endocrinology; 2000 Feb; 141(2):564-70. PubMed ID: 10650937
[TBL] [Abstract][Full Text] [Related]
36. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.
Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA
Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166
[TBL] [Abstract][Full Text] [Related]
37. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.
Lalou C; Lassarre C; Binoux M
Endocrinology; 1996 Aug; 137(8):3206-12. PubMed ID: 8754741
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.
Neely EK; Rosenfeld RG
Endocrinology; 1992 Feb; 130(2):985-93. PubMed ID: 1370799
[TBL] [Abstract][Full Text] [Related]
39. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor.
Gauguin L; Klaproth B; Sajid W; Andersen AS; McNeil KA; Forbes BE; De Meyts P
J Biol Chem; 2008 Feb; 283(5):2604-13. PubMed ID: 18048361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
